Open access · OA
via OpenAlex
Inflammatory Biomarkers in Hypertension
Panagiotis Tsioufis, Panagiotis Theofilis, Kyriakos S. Dimitriadis, Panayotis K. Vlachakis, Panagιotis Iliakis, Dimitris Tsiachris, Konstantinos P Tsioufis, Dimitris Tousoulis
Current Medicinal Chemistry · 2025 · ▲ 12 citations
Abstract
Hypertension remains a leading modifiable risk factor for cardiovascular diseases, yet its underlying mechanisms are not fully understood. Emerging evidence suggests that inflammation plays a central role in the pathogenesis and progression of hypertension. This review explores the association between inflammatory biomarkers, such as C-reactive protein (CRP), interleukin-6 (IL-6), and tumor necrosis factor-alpha (TNF-α), and hypertension. These biomarkers are not only indicators of inflammation but also active participants in the processes that elevate blood pressure, including endothelial dysfunction, oxidative stress, and immune system activation. Cytokines play a pivotal role in vascular remodeling and renal dysfunction, underscoring the inflammatory underpinnings of hypertension. Additionally, novel composite biomarkers like the monocyte-to-high-density lipoprotein ratio (MHR), systemic inflammation response index (SIRI), and systemic immune-inflammation index (SII) have been identified as valuable tools for assessing the inflammatory state in hypertensive patients. While renal denervation has emerged as a promising treatment for resistant hypertension, its impact on inflammatory biomarkers remains inconclusive, highlighting the need for further research.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.2174/0109298673348789250604113545
- Canonical
- link ↗
- Fetched
- 2026-10-16 MST
Cite this
APA
Tsioufis, P., Theofilis, P., Dimitriadis, K.S., Vlachakis, P.K., Iliakis, P., Tsiachris, D., Tsioufis, K.P., & Tousoulis, D. (2025). Inflammatory Biomarkers in Hypertension. <em>Current Medicinal Chemistry</em>. https://doi.org/10.2174/0109298673348789250604113545
Vancouver
Tsioufis P, Theofilis P, Dimitriadis KS, Vlachakis PK, Iliakis P, Tsiachris D, et al. Inflammatory Biomarkers in Hypertension. Current Medicinal Chemistry. 2025. doi:10.2174/0109298673348789250604113545.
BibTeX
@article{panagiotis2025Inflam,
title = {Inflammatory Biomarkers in Hypertension},
author = {Panagiotis Tsioufis and Panagiotis Theofilis and Kyriakos S. Dimitriadis and Panayotis K. Vlachakis and Panagιotis Iliakis and Dimitris Tsiachris and Konstantinos P Tsioufis and Dimitris Tousoulis},
journal = {Current Medicinal Chemistry},
year = {2025},
doi = {10.2174/0109298673348789250604113545},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Developmental medico-life-sciences 2026
Open access · CC-BY
Association of Circulating Inflammatory Biomarkers with Early Cognitive Decline in Patients with Alzheimer’s Disease: A Clinical Observational Study
Frontiers in Cardiovascular Medicine 2026
Open access · CC-BY
The role of IL-6 in atherosclerosis: a narrative review
Journal of Integrative Neuroscience 2024
Open access · CC-BY
Systematic Review and Metanalysis of the Expression of Blood-Based and Cerebrospinal Fluid-Based Biomarkers Related to Inflammatory Mediators in Neuropathic Pain
Journal of Clinical and Translational Science 2020
Open access · CC-BY
4311 Inflammatory biomarkers of cognitive dysfunction in pediatric obesity: associations between Executive Function, C-Reactive Protein, Interleukin 6, and Tumor Necrosis Factor alpha
European journal of ecology, biology and agriculture. 2026
Open access · CC-BY
Impact of Systemic Inflammatory Biomarkers on Atherosclerotic Progression and Clinical Outcomes in Women: A Case-Control Study
Bioinformation 2026
Open access · CC-BY